PIEZO1 and anemia: Similarly, a retrospective study of 126 individuals diagnosed with Piezo1-HX pointed to high variability in the clinical expression of Piezo1 mutation with clinical manifestations that include anemia, splenomegaly, and post-splenectomy thrombosis [11].